Sign In
test

Joseph Edelman

Perceptive Advisors Llc

Assets Managed
$5.118B
Holdings
94
Last Quarter
2026 - Q1
Filed Date
20d ago
Growth Rate
-8.78%(2Q avg: 26.61%)
Sustained Growth
0 quarters

Portfolio positions

This chart displays the top 10 holdings in Perceptive Advisors Llc's 2026 - Q1 portfolio, based on their 13F SEC filing, out of a total of 94 positions.

Assets under management

The assets under management (AUM) of Perceptive Advisors Llc over the past 10 years (40 quarters) show continuous growth in total asset value over the last 0 quarters. As of the latest 13F SEC filing for 2026 - Q1, they manage 5.118B in assets, with a quarterly growth rate of -8.78% and a 2-quarter average growth rate of 26.61%. The portfolio is managed by Joseph Edelman, and others.

Portfolio holdings

InvestmentPortfolio %Reported Value
PRAX
Praxis Precision Medicines I
Recent Activity
Increased 2.01%
12.82%
$655.974M
2.036M shares@ $322.19 avg price
CELC
Celcuity Inc
Recent Activity
Decreased -1.04%
6.98%
$356.939M
3.127M shares@ $114.14 avg price
ASND
Ascendis Pharma A S - Adr
Recent Activity
Increased 41.62%
6.85%
$350.282M
1.531M shares@ $228.73 avg price
ROIV
Roivant Sciences Ltd
Recent Activity
Increased 3.76%
4.49%
$229.507M
8.285M shares@ $27.71 avg price
CNTA
Centessa Pharmaceuticals-adr
Recent Activity
Increased 80.25%
4.09%
$208.884M
5.259M shares@ $39.72 avg price
RYTM
Rhythm Pharmaceuticals Inc
Recent Activity
Decreased -6.77%
4.04%
$206.449M
2.374M shares@ $86.97 avg price
SYRE
Spyre Therapeutics Inc
Recent Activity
Increased 23.27%
3.73%
$190.826M
3.783M shares@ $50.44 avg price
NUVL
Nuvalent Inc-a
Recent Activity
Decreased -5.08%
3.17%
$161.923M
1.581M shares@ $102.45 avg price
EWTX
Edgewise Therapeutics Inc
Recent Activity
Decreased -0.76%
2.73%
$139.355M
4.424M shares@ $31.5 avg price
PTGX
Protagonist Therapeutics Inc
Recent Activity
Decreased -8.85%
2.54%
$129.735M
1.231M shares@ $105.41 avg price

1-10 of 94